HGUC	High-Grade Urothelial Carcinoma
CIS	Carcinoma in situ
LGUC	Low-Grade Urothelial Carcinoma
NMIBC	Non-muscle invasive bladder carcinoma
MIBC	Muscle invasive bladder carcinoma
FDA	Food and Drug Administration
EMA	European Medicines Agency
BTA	Bladder Tumor Antigen
NMP22	Nuclear Matrix Protein 22
CFHrp	Complement factor H-related protein
BCG	Bacillus Calmette–Guerin
NMPs	Nuclear Matrix Protein
FISH	Fluorescence in situ hybridization
ELISA	Enzyme-linked immunosorbent assay
qPCR	Quantitative real-time polymerase chain reaction
TURB	Transurethral resection of the bladder
EAU	European Association of Urology
TPS	The Paris System for Reporting Urinary Cytology
WHO	World Health Organization
TNM	Tumor, node, and metastasis
NHGUC	Negative for High Grade Urothelial Carcinoma
AUC	Atypical Urothelial Cells
SHGUC	Suspicious for High Grade Urothelial Carcinoma
PPV	Positive predictive value
NPV	Negative predictive value
ROC	Receiver Operating Characteristic
UC	Urothelial carcinoma
PDD	Photodynamic diagnostics
UTUC	Upper Tract Urothelial Carcinoma
MCM5	Minichromosome Maintenance Protein 5
LDA	Laboratory-developed assay